Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2025 Filed Oct 7, 2025 21:08 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-25-000009 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2025 Filed Oct 7, 2025 21:08 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $60.56 | $121,120.00 |
DisclosureSEC source: 0001061983-25-000009 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| October 07, 2025 Filed Oct 7, 2025 21:08 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001061983-25-000009 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2025 Filed Oct 6, 2025 20:27 UTC |
Kaye Edward M. MDDirector
|
SaleCommon Stock | 6,757 | $60.00 | $405,420.00 |
DisclosureSEC source: 0001061983-25-000008 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,778 Read SEC document |
| October 01, 2025 Filed Oct 1, 2025 20:26 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $55.05 | $275,250.00 |
DisclosureSEC source: 0001061983-25-000007 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 368,108 Read SEC document |
| September 30, 2025 Filed Sep 30, 2025 20:33 UTC |
Kaye Edward M. MDDirector
|
SaleCommon Stock | 6,695 | $55.08 | $368,760.60 |
DisclosureSEC source: 0001061983-25-000006 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,535 Read SEC document |
| September 23, 2025 Filed Sep 23, 2025 21:07 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-25-000005 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2025 Filed Sep 23, 2025 21:07 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $49.28 | $98,560.00 |
DisclosureSEC source: 0001061983-25-000005 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| September 23, 2025 Filed Sep 23, 2025 21:07 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001061983-25-000005 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2025 Filed Sep 15, 2025 20:47 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $49.77 | $248,850.00 |
DisclosureSEC source: 0001061983-25-000004 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 373,108 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 20:13 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-021253 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 20:13 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $51.29 | $102,580.00 |
DisclosureSEC source: 0001127602-25-021253 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 20:13 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-021253 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:41 UTC |
Kaye Edward M. MDDirector
|
SaleCommon Stock | 6,756 | $50.00 | $337,800.00 |
DisclosureSEC source: 0001127602-25-021074 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,230 Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:34 UTC |
Harrington Robert ArthurDirector
|
SaleCommon Stock | 2,150 | $48.67 | $104,640.50 |
DisclosureSEC source: 0001127602-25-021071 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,493 Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:31 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $48.76 | $243,800.00 |
DisclosureSEC source: 0001127602-25-021070 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 378,108 Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-020711 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $38.31 | $76,620.00 |
DisclosureSEC source: 0001127602-25-020711 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-020711 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 20, 2025 12:04 UTC |
Daly James MDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 27,450 | $0.00 Strike: $37.84 | $0.00 |
DisclosureSEC source: 0001127602-25-020750 · form4.xml · derivative · entry 1 Daly James M · CIK 0001560782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,450 Underlying: Common Stock · 27,450 shares Expires 2035-08-19 F1 · kind: Initial Grant to New Director. Read SEC document |
| August 15, 2025 Filed Aug 15, 2025 20:23 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $38.42 | $192,100.00 |
DisclosureSEC source: 0001127602-25-020507 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 383,108 Read SEC document |
| August 05, 2025 Filed Aug 5, 2025 22:28 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-020109 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2025 Filed Aug 5, 2025 22:28 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $36.34 | $72,680.00 |
DisclosureSEC source: 0001127602-25-020109 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| August 05, 2025 Filed Aug 5, 2025 22:28 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-020109 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 20:38 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $36.45 | $182,250.00 |
DisclosureSEC source: 0001127602-25-019804 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 388,108 Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 15:01 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-019506 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 15:01 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $37.47 | $74,940.00 |
DisclosureSEC source: 0001127602-25-019506 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| July 22, 2025 Filed Jul 23, 2025 15:01 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-019506 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:48 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 559 | $38.01 | $21,247.59 |
DisclosureSEC source: 0001127602-25-019293 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,240 F1 · kind: Director equity in lieu of cash retainer program. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:45 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 164 | $38.01 | $6,233.64 |
DisclosureSEC source: 0001127602-25-019292 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,774 F1 · kind: Director equity in lieu of cash retainer program. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:44 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 164 | $38.01 | $6,233.64 |
DisclosureSEC source: 0001127602-25-019290 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,345 F1 · kind: Director equity in lieu of cash retainer program. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:43 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 328 | $38.01 | $12,467.28 |
DisclosureSEC source: 0001127602-25-019288 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,986 F1 · kind: Director equity in lieu of cash retainer program. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:41 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 328 | $38.01 | $12,467.28 |
DisclosureSEC source: 0001127602-25-019287 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,643 F1 · kind: Director equity in lieu of cash retainer program. Read SEC document |
| July 14, 2025 Filed Jul 15, 2025 21:38 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $38.15 | $190,750.00 |
DisclosureSEC source: 0001127602-25-019221 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 393,108 Read SEC document |
| July 08, 2025 Filed Jul 8, 2025 20:21 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-019021 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2025 Filed Jul 8, 2025 20:21 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $33.76 | $67,520.00 |
DisclosureSEC source: 0001127602-25-019021 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| July 08, 2025 Filed Jul 8, 2025 20:21 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-019021 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 19:51 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $33.55 | $167,750.00 |
DisclosureSEC source: 0001127602-25-018622 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,108 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:27 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-017640 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:27 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $32.91 | $65,820.00 |
DisclosureSEC source: 0001127602-25-017640 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| June 17, 2025 Filed Jun 17, 2025 20:27 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-017640 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2025 Filed Jun 16, 2025 21:19 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $33.80 | $169,000.00 |
DisclosureSEC source: 0001127602-25-017580 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,108 Read SEC document |
| June 05, 2025 Filed Jun 5, 2025 20:42 UTC |
Kaye Edward M. MDDirector
|
SaleCommon Stock | 3,636 | $32.10 | $116,715.60 |
DisclosureSEC source: 0001127602-25-016870 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,658 Read SEC document |
| June 05, 2025 Filed Jun 5, 2025 20:38 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 8,659 | $32.04 | $277,434.36 |
DisclosureSEC source: 0001127602-25-016865 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,028 Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-016470 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $31.88 | $63,760.00 |
DisclosureSEC source: 0001127602-25-016470 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-016470 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 2, 2025 20:33 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $31.22 | $156,100.00 |
DisclosureSEC source: 0001127602-25-016207 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,108 Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:02 UTC |
Lee SungEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 4,965 | $31.21 | $154,957.65 |
DisclosureSEC source: 0001127602-25-016416 · form4.xml · nonDerivative · entry 1 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,477 F1 · kind: Transactions represent withholding of restricted stock units upon vesting of 13,874 restricted stock units. Reporting person received 8,909 net shares of common stock after the withholding transaction.. Read SEC document |
| May 20, 2025 Filed May 20, 2025 20:28 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-015023 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.